Shigeki Hirabayashi

Assistant Professor

Kyushu University Graduate School of Medical Sciences

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Takahiro Maeda

Professor

Kyushu University Graduate School of Medical Sciences

JAPAN

View details

Kotaro Shirakawa

講師 / Senior Lecturer/ Junior Associate Professor

Kyoto University

JAPAN

View details

Kiyoko Miyata

Assistant Professor (Precision Medicine)

Kyushu University Graduate School of Medical Sciences

JAPAN

View details

Satoshi Takahashi

JAPAN

View details

Yuichiro Semba

Kyushu University

JAPAN

View details

Shinichi Kako

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shigeki Hirabayashi

Research Interests

Explore related searches

Contact this professor

Articles (10)

Targeting a mitochondrial E3 ubiquitin ligase complex to overcome AML cell-intrinsic Venetoclax resistance.

Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ALL: A retrospective nationwide study

HTLV-1 bZIP factor impairs DNA mismatch repair system

Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients.

Effect of Multiple HLA Locus Mismatches on Outcomes after Single Cord Blood Transplantation.

Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemia

Differential Effect of Graft-versus-Host Disease on Survival in Acute Leukemia according to Donor Type

The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia.

Personalized prediction of overall survival in patients with AML in non‐complete remission undergoing allo‐HCT

Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy‐refractory or relapsed disease prior to allogeneic stem cell transplantation

Collaborators (6)

Takahiro Maeda

Kotaro Shirakawa

Kiyoko Miyata

Satoshi Takahashi

Yuichiro Semba

Shinichi Kako

Make your next move.